Mok, T. S.K. et al. 2004. A phase I safety and pharmacokinetic study of OGT 719 in patients with liver cancer. Acta Oncologica. 43, 3 (Apr. 2004), 245–251. DOI:https://doi.org/10.1080/02841860310023525.